- In February 2025, Sernova Biotherapeutics announced that it had submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to assess its Cell Pouch, auto-transplanted with thyroid cells, in patients undergoing total thyroidectomy for nodular thyroid disease.
- In October 2024, Acella Pharmaceuticals, announced its partnership with Paloma Health, a virtual medical practice specializing in the telehealth treatment of hypothyroidism and Hashimoto’s disease. This collaboration aims to close the gap between patients experiencing hypothyroid symptoms and healthcare providers open to exploring all treatment options. Both Acella Pharmaceuticals and Paloma Health share a commitment to enhancing outcomes for those living with hypothyroidism.
- In May 2023, Merck, in collaboration with Indonesian medical associations, launched the Thyroid RAISE program to enhance healthcare professionals’ capabilities and increase public awareness about thyroid disorders, including Hashimoto’s
